Corbus Pharmaceuticals Holdings, Inc (CRBP) insider trading
Every open-market stock purchase and sale by Corbus Pharmaceuticals Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $101K over the last 12 months (1 buy).
- Insiders sold $1.4M over the last 12 months (13 sales).
- Last insider buy: Nishant C Saxena (C-suite exec), $68.2K, 4 months ago.
Last 12 months: insiders bought $101K (1 buy) and sold $1.4M (13 sales). Last close $7.56 on Jun 4, 2026.
Recent CRBP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | John Kenneth Jenkins (Insider) | Sold | $38K |
| Jun 10, 2026 | Anne Altmeyer (Insider) | Sold | $19.1K |
| Jun 10, 2026 | Winston Kung (Insider) | Sold | $16K |
| Jun 3, 2026 | Nishant C Saxena (C-suite exec) | Bought | $68.2K |
| Jun 2, 2026 | Nishant C Saxena (C-suite exec) | Bought | $33K |
| May 21, 2026 | Nishant C Saxena (C-suite exec) | Bought (not open market) | — |
| May 21, 2026 | Nishant C Saxena (C-suite exec) | Bought (not open market) | — |
| May 19, 2026 | Brent Pfeiffenberger (Insider) | Bought (not open market) | — |
| May 19, 2026 | Yong Ben (Insider) | Bought (not open market) | — |
| May 19, 2026 | Anne Altmeyer (Insider) | Bought (not open market) | — |
| May 19, 2026 | Anne Altmeyer (Insider) | Bought (not open market) | — |
| May 19, 2026 | Rachelle Suzanne Jacques (Insider) | Bought (not open market) | — |
| May 19, 2026 | Rachelle Suzanne Jacques (Insider) | Bought (not open market) | — |
| May 19, 2026 | John Kenneth Jenkins (Insider) | Bought (not open market) | — |
| May 19, 2026 | John Kenneth Jenkins (Insider) | Bought (not open market) | — |
| May 19, 2026 | Brent Pfeiffenberger (Insider) | Bought (not open market) | — |
| May 19, 2026 | Yong Ben (Insider) | Bought (not open market) | — |
| May 19, 2026 | Winston Kung (Insider) | Bought (not open market) | — |
| May 19, 2026 | Winston Kung (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | Dominic Smethurst (C-suite exec) | Sold | $50.6K |
| Feb 17, 2026 | Ian Hodgson (COO) | Sold | $6.3K |
| Feb 13, 2026 | Yuval Cohen (CEO) | Sold | $108K |
| Feb 13, 2026 | Sean F. Moran (CFO) | Sold | $36.6K |
| Feb 3, 2026 | Dominic Smethurst (C-suite exec) | Sold | $26.6K |
| Feb 3, 2026 | Ian Hodgson (COO) | Sold | $19.5K |
Who's trading CRBP
- John Kenneth Jenkins, Insider: sold $38K (1 sale), last Jun 10, 2026
- Anne Altmeyer, Insider: sold $40.8K (2 sales), last Jun 10, 2026
- Winston Kung, Insider: sold $16K (1 sale), last Jun 10, 2026
- Nishant C Saxena, C-suite exec: bought $101K (2 buys), last Jun 3, 2026
- Rachelle Suzanne Jacques, Insider: other filings, last May 19, 2026
- Yong Ben, Insider: other filings, last May 19, 2026
- Brent Pfeiffenberger, Insider: other filings, last May 19, 2026
- Dominic Smethurst, C-suite exec: sold $77.2K (2 sales), last Mar 2, 2026
- Ian Hodgson, COO: sold $25.8K (2 sales), last Feb 17, 2026
- Yuval Cohen, CEO: sold $579K (3 sales), last Feb 13, 2026
- Sean F. Moran, CFO: sold $258K (2 sales), last Feb 13, 2026
- Cormorant Asset Management LP, Insider: sold $344K (1 sale), last Dec 11, 2025
Get free alerts when an insider at Corbus Pharmaceuticals Holdings, Inc files a new trade →